These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease. Choudhry MN; Soran H; Ziglam HM QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220 [TBL] [Abstract][Full Text] [Related]
5. ACP Journal Club. Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MI. Aronow HD Ann Intern Med; 2010 Dec; 153(12):JC6-13. PubMed ID: 21173402 [No Abstract] [Full Text] [Related]
6. A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Naggie S; Miller BA; Zuzak KB; Pence BW; Mayo AJ; Nicholson BP; Kutty PK; McDonald LC; Woods CW Am J Med; 2011 Mar; 124(3):276.e1-7. PubMed ID: 21396512 [TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577 [TBL] [Abstract][Full Text] [Related]
9. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Aseeri M; Schroeder T; Kramer J; Zackula R Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653 [TBL] [Abstract][Full Text] [Related]
10. ACP Journal Club. Review: Fidaxomicin is better than vancomycin for Clostridium difficile recurrence. Pegues DA Ann Intern Med; 2012 Apr; 156(8):JC4-09. PubMed ID: 22508749 [No Abstract] [Full Text] [Related]
11. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure. Stevens V; Dumyati G; Brown J; Wijngaarden E Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992 [TBL] [Abstract][Full Text] [Related]
12. ACP Journal Club. Concurrent PPIs and antibiotics for incident C. difficile infection were associated with increased risk for recurrent infection. Fekete T Ann Intern Med; 2010 Oct; 153(8):JC4-12. PubMed ID: 20956696 [No Abstract] [Full Text] [Related]
13. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086 [TBL] [Abstract][Full Text] [Related]
14. ACP Journal Club. Proton-pump inhibitors were associated with reduced effectiveness of alendronate for preventing hip fractures. Ito K Ann Intern Med; 2011 Oct; 155(8):JC4-13. PubMed ID: 22007072 [No Abstract] [Full Text] [Related]
15. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy. King RN; Lager SL Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450 [TBL] [Abstract][Full Text] [Related]
16. ACP Journal Club. Concomitant use of proton pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI. Granger CB Ann Intern Med; 2009 Aug; 151(4):JC2-13. PubMed ID: 19687487 [No Abstract] [Full Text] [Related]
17. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794 [TBL] [Abstract][Full Text] [Related]